Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DEVELOPMENT OF PROGNOSTIC PLATELET RNA BIOMARKERS TO TAILOR ANTIPLATELET THERAPY

NCT05278637 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05278637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05278637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DEVELOPMENT OF PROGNOSTIC PLATELET RNA BIOMARKERS TO TAILOR ANTIPLATELET THERAPY
Lead sponsor
Duke University
Phase
Phase 1
Overall status
Completed
Start date
November 1, 2013
Completion date
December 5, 2016
Enrollment
135 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, platelet aggregation inhibitors, rna, ticagrelor